Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
NYS Entity Status
NYS Filing Date
JANUARY 14, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - MRK UNIVERSAL, LLC
Around the Web
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- NY state's new free tuition program covers 22K students
Monday Oct 2, 2017
ALBANY, N.Y. (AP) — New York Gov. Andrew Cuomo says the state's first-in-the-nation tuition-free college program will pay the bill for about 22,000 students this year.The governor's office says an additional 23,000 students who applied also qualified to have their tuition covered, but by existing state and federal financial aid.About 75,000 people applied for the new Excelsior Scholarship, which pays the balance of tuition for New York residents from families earning $100,000 or less who attend a State University of New York or City University of New York school full-time.Cuomo says thanks to the new program 53 percent of full-time SUNY and CUNY in-state students now go to school tuition-free.
- FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths
By Frank Vinluan - Wednesday Jul 5, 2017
Nearly a month after Merck paused enrollment in three clinical trials in multiple myeloma to gather more information about patient deaths, the FDA has now put a stop to those studies altogether. Merck (NYSE: MRK) said Wednesday that the FDA has placed a complete hold on two Phase 3 trials testing its immunotherapy drug pembrolizumab […]
- Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug
By Frank Vinluan - Wednesday Oct 11, 2017
Merck is pulling the plug on a cholesterol-lowering drug that met its main goal in a clinical trial but still raised questions about whether it would benefit patients. Kenilworth, NJ-based Merck (NYSE: MRK) said Wednesday that it won’t seek regulatory approval for anacetrapib, a drug that inhibits a protein called cholesterolylester transfer protein (CETP). By […]